Hemostats Market – Global Forecasts to 2025

Global Hemostats Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025
[83 pages report] This market research report includes a detailed segmentation of the global Hemostats market by type (active Hemostats, passive Hemostats, combination Hemostats), by product (thrombin-based Hemostats, gelatin-based Hemostats, collagen-based Hemostats, oxidized regenerated cellulose-based Hemostats, combination Hemostats, others), and by region (North America, Europe, Asia Pacific, Rest of the World)
Overview of the Global Hemostats Market
The  market research report predicts that the “Global Hemostats Market” will grow at a CAGR of 6.2% during the forecast period 2019–2025. The market has witnessed steady growth in the past few years and is sustaining due to the increasing number of surgical procedures, growing incidence of sports-related injuries, and increasing focus on effective blood loss management.

Increase in the number of outpatient procedures, increasing focus on emerging markets, and increase in healthcare spending are providing opportunities for the growth of the Hemostats market. Vendors are concentrating on new product launch across the therapeutic areas. The majority of the revenue is generated from the leading players in the market with sales dominated by B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Johnson & Johnson, Medtronic Plc, Advanced Medical Solution Group Plc, Pfizer, Biom’Up, Gelita GmbH, CryoLife Inc., Integra LifeScience, Z-Medica, and Teleflex (Vascular Solutions).
North America accounted for the largest share of the global Hemostats market in 2018. The Asia Pacific region is expected to witness the fastest growth rate due to the availability of a large patient pool, increasing surgeries, and rising healthcare expenditure.
By Product:
• Thrombin-based Hemostats
• Gelatin-based Hemostats
• Collagen-based Hemostats
• Oxidized Regenerated Cellulose-based Hemostats
• Combination Hemostats
• Others
Among the products, the higher efficacy has made thrombin-based Hemostats the major shareholder in the market. Combination agents are profiting from the highest growth rate as medical practitioner take on more complex and risky procedures that necessitate efficient, fast-acting products for successful control of bleeding.
By Type:
• Active Hemostats
• Passive Hemostats
• Combination Hemostats
Active Hemostats hold a significant market share, followed by combination Hemostats. In June 2017, Ethicon received the FDA approval for Surgicel Powder Absorbable Haemostat.
By Regions:
• North America
• Europe
• APAC
• RoW
North America dominated the global Hemostats market in 2018. The significant share of the North American region comes from the US due to the accessibility to good quality healthcare and good reimbursement facilities.
Hemostats Market Research Competitive Analysis – Mergers & acquisitions have been the primary strategy followed by major players to maintain their leadership in the market. In 2017, Teleflex acquired Vascular Solutions. In March 2018, Baxter acquired RECOTHROM and PREVELEAK from Mallinckrodt plc to broaden surgical haemostat and sealant portfolio. New products launched are posing a threat to previously available products in the market. In January 2019, the US FDA approved the marketing of HEMOBLAST Bellows Laparoscopic Applicator for all minimally-invasive procedures. To aid this, Biom’Up has trained nearly 200 medical professionals in the US and Europe for the use of product far ahead of the launch.

Key Vendors:
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• Johnson & Johnson
• Medtronic Plc
• Advanced Medical Solution Group Plc
• Pfizer
Key Competitive Facts
• Ethicon (J&J), Baxter International, and Pfizer are the three major players in the market.
• The primary focus among the players in the market is to develop Hemostats that reduce significant time during the surgery procedure.
Benefits – The report provides complete details about the sub-segments of the Hemostats market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the disease management in the upcoming years along with details of the existing pure-play companies and new players entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:
• Understanding the potential market opportunity with precise market size and forecast data.
• A detailed market analysis focusing on the growth of the Hemostats industry.
• Factors influencing the growth of the Hemostats market.
• In-depth competitive analysis of dominant and pure-play vendors.
• Prediction analysis of the Hemostats market in both developed and developing regions.
• Key insights related to major segments of the Hemostats market.
• Latest market trend analysis impacting the buying behavior of the consumers.
Key Stakeholders
 


1 Industry Outlook 7
1.1 Industry Overview 7
1.2 Total Addressable Market 8
1.3 Industry Trends 9
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 10
2.3 Research Methodology 12
2.4 Report Assumptions 12
3 Market Snapshot 13
3.1 Market Definition – Infoholic Research 13
3.2 Segmented Addressable Market 13
3.2.1 Characteristics of an Ideal Hemostatic Agent 13
3.2.2 Regulatory Scenario 14
3.3 Industry Trends 15
3.4 Related Market 15
3.4.1 Wound Biologics 15
3.4.1.1 Trends in the wound biologics market 16
4 Market Outlook 17
4.1 Reimbursement 17
4.2 Market Segmentation 18
4.3 Porter 5 (Five) Forces 18
5 Market Characteristics 21
5.1 Market Dynamics 21
5.1.1 Drivers 22
5.1.1.1 Increase in the number of surgical procedures 22
5.1.1.2 Growing incidence of sports-related injuries 22
5.1.1.3 Increasing focus on effective blood loss management 23
5.1.2 Restraints 24
5.1.2.1 Stringent regulatory approval process 24
5.1.2.2 High cost of hemostats 24
5.1.2.3 Availability of alternatives 24
5.1.3 Opportunities 25
5.1.3.1 Increase in healthcare spending 25
5.1.3.2 Increase in the number of outpatient procedures 25
5.1.3.3 Market expansion opportunities in emerging nations 25
5.1.4 DRO – Impact Analysis 27
5.2 Key Stakeholders 28
6 Products: Market Size and Analysis 29
6.1 Overview 29
6.2 Thrombin-based Hemostats 31
6.3 Gelatin-based Hemostats 32
6.4 Collagen-based Hemostats 33
6.5 Oxidized Regenerated Cellulose-based Hemostats 34
6.6 Combination Hemostats 35
6.7 Others 36
7 Types: Market Size and Analysis 38
7.1 Overview 38
7.2 Passive Hemostats 39
7.3 Active Hemostats 40
7.4 Combination Hemostats 41
8 Regions: Market Size and Analysis 43
8.1 Overview 43
8.2 North America 44
8.2.1 Overview 44
8.3 Europe 46
8.3.1 Overview 46
8.4 Asia Pacific 48
8.4.1 Overview 48
8.5 Rest of the World 49
8.5.1 Overview 49
9 Competitive Landscape 51
10 Vendors Profile 53
10.1 B. Braun Melsungen AG 53
10.2 Baxter International Inc. 56
10.3 Becton Dickinson and Company 59
10.4 Johnson and Johnson 62
10.5 Medtronic Plc (Covidien Plc) 65
10.6 Advanced Medical Solutions Group Plc 68
10.7 Pfizer 70
11 Companies to Watch for 74
11.1 Biom’Up 74
11.2 Gelita AG 75
11.3 CryoLife Inc. 75
11.4 Integra LifeSciences 77
11.5 Z-Medica 78
11.6 Teleflex (Vascular Solutions) 79
Annexure 81
Abbreviations 81
 


List Of Tables



TABLE 1 HEMOSTATS PRODUCTS AND CATEGORIES 29
TABLE 2 HEMOSTATS MARKET REVENUE, BY PRODUCT, 2018–2025 ($MILLION) 30
TABLE 3 PRODUCT LIST 31
TABLE 4 HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION) 38
TABLE 5 PRODUCT LIST 39
TABLE 6 HEMOSTATS MARKET REVENUE, BY GEOGRAPHY, 2018–2025 ($MILLION) 44
TABLE 7 BUSINESS SUMMARY: B BRAUN MELSUNGEN AG 55
TABLE 8 BUSINESS SUMMARY: BAXTER INTERNATIONAL INC. 58
TABLE 9 BUSINESS SUMMARY: BECTON DICKINSON AND COMPANY 61
TABLE 13 BUSINESS SUMMARY: PFIZER 72
TABLE 14 BUSINESS SUMMARY: BIOM’UP 74
TABLE 15 BUSINESS SUMMARY: GELITA AG 75
TABLE 16 BUSINESS SUMMARY: CRYOLIFE INC 76
TABLE 17 BUSINESS SUMMARY: INTEGRA LIFESCIENCE 77
TABLE 18 BUSINESS SUMMARY: COMPANY NAME 78
TABLE 19 BUSINESS SUMMARY: TELEFLEX INCORPORATED 79
 


List Of Figures



CHART 1 RESEARCH METHODOLOGY OF GLOBAL HEMOSTATS MARKET 12
CHART 2 HEMOSTATS MARKET REVENUE, 2018–2025 ($MILLION) 14
CHART 3 HEMOSTATS MARKET SEGMENTATION 18
CHART 4 PORTERS 5 FORCES ON HEMOSTATS MARKET 18
CHART 5 PEST ANALYSIS OF HEMOSTATS MARKET 20
CHART 6 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES 21
CHART 7 DRO - IMPACT ANALYSIS OF HEMOSTATS MARKET 27
CHART 8 KEY STAKEHOLDERS OF HEMOSTATS MARKET 28
CHART 9 HEMOSTATS MARKET SEGMENT REVENUE, BY PRODUCT, 2018 ($MILLION) 30
CHART 10 THROMBIN BASED HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION) 31
CHART 11 GELATIN BASED HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION) 33
CHART 12 COLLAGEN BASED HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION) 34
CHART 13 OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION) 35
CHART 14 COMBINATION HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION) 36
CHART 15 OTHER HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION) 37
CHART 16 HEMOSTATS MARKET SEGMENT REVENUE, BY TYPE, 2018-2025 ($MILLION) 38
CHART 17 PASSIVE HEMOSTATS MARKET SEGMENT REVENUE, BY TYPE, 2018-2025 ($MILLION) 40
CHART 18 ACTIVE HEMOSTATS MARKET SEGMENT REVENUE, BY TYPE, 2018-2025 ($MILLION) 40
CHART 19 COMBINATION HEMOSTATS MARKET SEGMENT REVENUE, BY TYPE, 2018-2025 ($MILLION) 42
CHART 20 HEMOSTATS MARKET BY REGIONAL SEGMENTATION, 2018 (%) 43
CHART 21 HEMOSTATS MARKET BY REGIONAL SEGMENTATION, 2025 (%) 43
CHART 22 HEMOSTATS MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION) 45
CHART 23 HEMOSTATS MARKET REVENUE IN US 2018 (%SHARE) 46
CHART 24 HEMOSTATS MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION) 47
CHART 25 HEMOSTATS MARKET REVENUE IN EUROPE, BY COUNTRIES 2018 (%SHARE) 47
CHART 26 HEMOSTATS MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION) 48
CHART 27 HEMOSTATS MARKET REVENUE IN REST OF THE WORLD, 2018–2025 ($MILLION) 49
CHART 28 PRODUCT MATRIX 52
 


Hemostats Market – Global Forecasts to 2025

Hemostats Market Global Forecasts to 2025 market research report available in single user pdf license with Aarkstore Enterprise at USD 2750

USD 2750 View Report

Asia Pacific Surgical Hemostats Internal Tissue Sealants And Adhesion Barriers Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Surgical Hemostats Internal Tissue Sealants And Adhesion Barriers market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected

USD 3000 View Report

Global Human Milk Oligosaccharides Market – Trends & Forecast, 2019-2025

Human Milk Oligosaccharides Market Research Report - Global Forecast till 2025Global Human Milk Oligosaccharides Market Information: Information by Type (Neutral and Acidic), Application (Food Industry and Laboratory Research) and Region

USD 4450 View Report

Global Floating Production System (FPS) Market – Analysis By Platform Type (Tension Leg, Semi-Submersible, SPAR, FPSO, Drill Ships, Others), Application (Shallow Water, Deep Water, Ultra-Deep Water), By Region, By Country (2019 Edition): Forecast to 2024

Executive A comprehensive research report created through extensive primary research (inputs from industry experts, companies and stakeholders) and secondary research, the report aims to present the analysis of Global Floating

USD 2400 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available